FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1856238641> ?p ?o ?g. }

• W1856238641 endingPage "107" @default.
• W1856238641 startingPage "100" @default.
• W1856238641 abstract "Adipose tissue through the many secreted adipocytokines creates a highly active metabolic and endocrine organ. The evaluation of serum adipocytokine concentration in children with chronic kidney disease (CKD) could serve as a marker of cardio-vascular complication progression and an index of outcome in adulthood and after kidney transplantation.The aim of the study was to evaluate simultaneously the serum concentrations of six different adipocytokines: adiponectin, apelin, chemerin, omentin, resistin, and vaspin, in 28 children with CKD stage 5 on haemodialysis and peritoneal dialysis.The concentration of apelin, omentin, and resistin in children with CKD was significantly higher and the concentration of vaspin, adiponectin, and chemerin was significantly lower than in the control group. After adjusting to body mass index (BMI), the same results were obtained. After adjusting to body surface area (BSA), the concentration of vaspin, adiponectin, and chemerin did not differ between children with CKD and the control group. In analysis of the correlation between serum total adipocytokine levels in children with CKD we found a negative relationship in pairs: omentin-apelin and omentin-vaspin, and positive in pairs: adiponectin-chemerin and adiponectin-resistin.Our results show that changes in serum adipocytokines concentration are associated with the kidney dysfunction in CKD in children. Longitudinal studies on larger groups of paediatric cohorts would be helpful in investigating whether adipocytokines play a harmful role in the development of CKD and would enable further understanding of the risk factors for CKD progression." @default.
• W1856238641 created "2016-06-24" @default.
• W1856238641 creator A5001474605 @default.
• W1856238641 creator A5035649075 @default.
• W1856238641 creator A5038642438 @default.
• W1856238641 creator A5038816292 @default.
• W1856238641 creator A5040641887 @default.
• W1856238641 creator A5058103146 @default.
• W1856238641 creator A5066498137 @default.
• W1856238641 creator A5086401748 @default.
• W1856238641 date "2015-05-01" @default.
• W1856238641 modified "2023-10-16" @default.
• W1856238641 title "Ocena stężenia adypocytokin u dzieci z przewlekłą chorobą nerek" @default.
• W1856238641 cites W1939810769 @default.
• W1856238641 cites W1941865682 @default.
• W1856238641 cites W1975255165 @default.
• W1856238641 cites W1977514022 @default.
• W1856238641 cites W1985044674 @default.
• W1856238641 cites W1987965279 @default.
• W1856238641 cites W1994278956 @default.
• W1856238641 cites W2005871724 @default.
• W1856238641 cites W2008621690 @default.
• W1856238641 cites W2010459039 @default.
• W1856238641 cites W2026062733 @default.
• W1856238641 cites W2029413179 @default.
• W1856238641 cites W2043009367 @default.
• W1856238641 cites W2051051060 @default.
• W1856238641 cites W2069390286 @default.
• W1856238641 cites W2071777955 @default.
• W1856238641 cites W2076009490 @default.
• W1856238641 cites W2105506930 @default.
• W1856238641 cites W2106616059 @default.
• W1856238641 cites W2121777123 @default.
• W1856238641 cites W2124589753 @default.
• W1856238641 cites W2147468118 @default.
• W1856238641 cites W2154884371 @default.
• W1856238641 cites W2163154401 @default.
• W1856238641 cites W2165804582 @default.
• W1856238641 cites W2166091129 @default.
• W1856238641 cites W2171646385 @default.
• W1856238641 cites W2328249312 @default.
• W1856238641 cites W2408643087 @default.
• W1856238641 cites W2125522362 @default.
• W1856238641 doi "https://doi.org/10.5603/ep.2015.0015" @default.
• W1856238641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25931038" @default.
• W1856238641 hasPublicationYear "2015" @default.
• W1856238641 type Work @default.
• W1856238641 sameAs 1856238641 @default.
• W1856238641 citedByCount "7" @default.
• W1856238641 countsByYear W18562386412016 @default.
• W1856238641 countsByYear W18562386412017 @default.
• W1856238641 countsByYear W18562386412019 @default.
• W1856238641 countsByYear W18562386412020 @default.
• W1856238641 countsByYear W18562386412021 @default.
• W1856238641 countsByYear W18562386412022 @default.
• W1856238641 crossrefType "journal-article" @default.
• W1856238641 hasAuthorship W1856238641A5001474605 @default.
• W1856238641 hasAuthorship W1856238641A5035649075 @default.
• W1856238641 hasAuthorship W1856238641A5038642438 @default.
• W1856238641 hasAuthorship W1856238641A5038816292 @default.
• W1856238641 hasAuthorship W1856238641A5040641887 @default.
• W1856238641 hasAuthorship W1856238641A5058103146 @default.
• W1856238641 hasAuthorship W1856238641A5066498137 @default.
• W1856238641 hasAuthorship W1856238641A5086401748 @default.
• W1856238641 hasBestOaLocation W18562386411 @default.
• W1856238641 hasConcept C126322002 @default.
• W1856238641 hasConcept C134018914 @default.
• W1856238641 hasConcept C170493617 @default.
• W1856238641 hasConcept C194832188 @default.
• W1856238641 hasConcept C199901988 @default.
• W1856238641 hasConcept C2776782570 @default.
• W1856238641 hasConcept C2777391703 @default.
• W1856238641 hasConcept C2778653478 @default.
• W1856238641 hasConcept C2779056158 @default.
• W1856238641 hasConcept C2779546753 @default.
• W1856238641 hasConcept C2779760629 @default.
• W1856238641 hasConcept C2780221984 @default.
• W1856238641 hasConcept C2780613262 @default.
• W1856238641 hasConcept C511355011 @default.
• W1856238641 hasConcept C555293320 @default.
• W1856238641 hasConcept C71924100 @default.
• W1856238641 hasConceptScore W1856238641C126322002 @default.
• W1856238641 hasConceptScore W1856238641C134018914 @default.
• W1856238641 hasConceptScore W1856238641C170493617 @default.
• W1856238641 hasConceptScore W1856238641C194832188 @default.
• W1856238641 hasConceptScore W1856238641C199901988 @default.
• W1856238641 hasConceptScore W1856238641C2776782570 @default.
• W1856238641 hasConceptScore W1856238641C2777391703 @default.
• W1856238641 hasConceptScore W1856238641C2778653478 @default.
• W1856238641 hasConceptScore W1856238641C2779056158 @default.
• W1856238641 hasConceptScore W1856238641C2779546753 @default.
• W1856238641 hasConceptScore W1856238641C2779760629 @default.
• W1856238641 hasConceptScore W1856238641C2780221984 @default.
• W1856238641 hasConceptScore W1856238641C2780613262 @default.
• W1856238641 hasConceptScore W1856238641C511355011 @default.
• W1856238641 hasConceptScore W1856238641C555293320 @default.
• W1856238641 hasConceptScore W1856238641C71924100 @default.
• W1856238641 hasIssue "2" @default.

• next